Patent · US Active

Compositions and methods for delivery of AAV

US11512327B2 · kind B2 · utility

2Cited by
185References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2018
Grant dateNov 29, 2022
Priority date
Expiry dateNov 20, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for the preparation, manufacture, formulation and therapeutic use of adeno-associated virus (AAV) particles for the prevention and/or treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.